HEADER NUCLEAR PROTEIN 28-JAN-22 7TRB TITLE CRYSTAL STRUCTURE OF FARNESOID X-ACTIVATED RECEPTOR COMPLEXED WITH TITLE 2 COMPOUND-32 AKA (1S,3S)-N-({4-[5-(2-FLUOROPR OPAN-2-YL)-1,2,4- TITLE 3 OXADIAZOL-3-YL]BICYCLO[2.2.2]OCTAN-1-YL}M ETHYL)-3-HYDROXY-N-[4'-(2- TITLE 4 HYDROXYPROPAN-2-YL)-[1,1'-BIPHEN YL]-3-YL]-3-(TRIFLUOROMETHYL) TITLE 5 CYCLOBUTANE-1-CARBOXAMIDE CAVEAT 7TRB RESIDUES PHE B 259 AND ILE B 260 THAT ARE NEXT TO EACH OTHER CAVEAT 2 7TRB IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE CAVEAT 3 7TRB BETWEEN C AND N IS 0.93 RESIDUES ILE B 260 AND MET B 261 CAVEAT 4 7TRB THAT ARE NEXT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT CAVEAT 5 7TRB PROPERLY LINKED: DISTANCE BETWEEN C AND N IS 0.93 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BILE ACID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FARNESOID X-ACTIVATED RECEPTOR,FARNESOL RECEPTOR HRR-1, COMPND 5 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 4,RETINOID X RECEPTOR- COMPND 6 INTERACTING PROTEIN 14,RXR-INTERACTING PROTEIN 14; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CO-ACTIVATOR; COMPND 10 CHAIN: C, D; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H4, BAR, FXR, HRR1, RIP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS NHR, FXR, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.A.KHAN,M.RUZANOV REVDAT 3 18-OCT-23 7TRB 1 REMARK REVDAT 2 27-JUL-22 7TRB 1 JRNL REVDAT 1 29-JUN-22 7TRB 0 JRNL AUTH S.J.NARA,S.JOGI,S.CHERUKU,S.KANDHASAMY,F.JAIPURI,P.K.KATHI, JRNL AUTH 2 S.REDDY,S.SARODAYA,E.M.COOK,T.WANG,D.SITKOFF,K.A.ROSSI, JRNL AUTH 3 M.RUZANOV,S.E.KIEFER,J.A.KHAN,M.GAO,S.REDDY, JRNL AUTH 4 S.SIVAPRASAD LVJ,R.SANE,K.MOSURE,X.ZHUO,G.G.CAO,M.ZIEGLER, JRNL AUTH 5 A.AZZARA,J.KRUPINSKI,M.G.SOARS,B.A.ELLSWORTH,D.A.WACKER JRNL TITL DISCOVERY OF BMS-986339, A PHARMACOLOGICALLY DIFFERENTIATED JRNL TITL 2 FARNESOID X RECEPTOR AGONIST FOR THE TREATMENT OF JRNL TITL 3 NONALCOHOLIC STEATOHEPATITIS. JRNL REF J.MED.CHEM. V. 65 8948 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35704802 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00165 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 68.4 REMARK 3 NUMBER OF REFLECTIONS : 17570 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 854 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 42 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 8.32 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 419 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2181 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 386 REMARK 3 BIN R VALUE (WORKING SET) : 0.2159 REMARK 3 BIN FREE R VALUE : 0.2421 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.88 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 33 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3607 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 13 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.18 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.76370 REMARK 3 B22 (A**2) : 0.58340 REMARK 3 B33 (A**2) : 1.18030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.360 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.595 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.281 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.663 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.287 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3891 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5388 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1312 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 696 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3891 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 509 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4460 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.27 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7TRB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1000262817. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5? REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17574 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 78.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 1.03700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3RUT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28.5% PEG2000MME 0.1M NAAC TRIHYDRATE REMARK 280 0.1M MES PH 6.5 10MM BME, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.35500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.63000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.35500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.63000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 226 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 HIS A 233 REMARK 465 HIS A 234 REMARK 465 HIS A 235 REMARK 465 SER A 236 REMARK 465 SER A 237 REMARK 465 GLY A 238 REMARK 465 GLU A 239 REMARK 465 THR A 240 REMARK 465 VAL A 241 REMARK 465 ARG A 242 REMARK 465 PHE A 243 REMARK 465 GLN A 244 REMARK 465 GLY A 245 REMARK 465 HIS A 246 REMARK 465 LEU A 278 REMARK 465 LYS A 279 REMARK 465 GLU A 280 REMARK 465 ALA A 281 REMARK 465 GLN A 476 REMARK 465 MET B 226 REMARK 465 GLY B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 HIS B 230 REMARK 465 HIS B 231 REMARK 465 HIS B 232 REMARK 465 HIS B 233 REMARK 465 HIS B 234 REMARK 465 HIS B 235 REMARK 465 SER B 236 REMARK 465 SER B 237 REMARK 465 GLY B 238 REMARK 465 GLU B 239 REMARK 465 THR B 240 REMARK 465 VAL B 241 REMARK 465 ARG B 242 REMARK 465 PHE B 243 REMARK 465 GLN B 244 REMARK 465 GLY B 245 REMARK 465 HIS B 246 REMARK 465 MET B 269 REMARK 465 PRO B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 ILE B 273 REMARK 465 THR B 274 REMARK 465 ASN B 275 REMARK 465 LYS B 276 REMARK 465 GLN B 476 REMARK 465 LYS C 744 REMARK 465 ASP C 745 REMARK 465 GLU C 757 REMARK 465 LYS D 744 REMARK 465 ASP D 756 REMARK 465 GLU D 757 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 247 CG SD CE REMARK 470 LYS A 266 CD CE NZ REMARK 470 GLN A 267 CG CD OE1 NE2 REMARK 470 MET A 269 SD CE REMARK 470 GLN A 271 CG CD OE1 NE2 REMARK 470 GLU A 272 CG CD OE1 OE2 REMARK 470 THR A 274 OG1 CG2 REMARK 470 LYS A 276 CE NZ REMARK 470 ILE A 277 CG1 CG2 CD1 REMARK 470 PHE A 282 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 286 CD OE1 OE2 REMARK 470 PHE A 288 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 GLU A 293 CG CD OE1 OE2 REMARK 470 GLU A 304 CD OE1 OE2 REMARK 470 GLN A 313 CG CD OE1 NE2 REMARK 470 GLU A 318 CD OE1 OE2 REMARK 470 LYS A 325 CD CE NZ REMARK 470 LYS A 343 CD CE NZ REMARK 470 LEU A 351 CG CD1 CD2 REMARK 470 LEU A 352 CG CD1 CD2 REMARK 470 ARG A 355 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 358 CG OD1 ND2 REMARK 470 ASP A 363 CG OD1 OD2 REMARK 470 GLU A 364 CG CD OE1 OE2 REMARK 470 LYS A 374 CD CE NZ REMARK 470 LYS A 380 CD CE NZ REMARK 470 ARG A 405 NE CZ NH1 NH2 REMARK 470 GLU A 406 CG CD OE1 OE2 REMARK 470 GLU A 409 CG CD OE1 OE2 REMARK 470 LYS A 410 CG CD CE NZ REMARK 470 ILE A 425 CG1 CG2 CD1 REMARK 470 HIS A 426 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 459 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 462 CG OD1 OD2 REMARK 470 LYS A 464 CG CD CE NZ REMARK 470 MET B 247 CG SD CE REMARK 470 ARG B 268 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 277 CG1 CG2 CD1 REMARK 470 LEU B 278 CG CD1 CD2 REMARK 470 LYS B 279 CG CD CE NZ REMARK 470 PHE B 282 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 285 CG CD OE1 OE2 REMARK 470 LEU B 289 CG CD1 CD2 REMARK 470 GLU B 293 CG CD OE1 OE2 REMARK 470 GLN B 313 CG CD OE1 NE2 REMARK 470 LYS B 342 CE NZ REMARK 470 LYS B 343 CE NZ REMARK 470 LEU B 352 CG CD1 CD2 REMARK 470 ARG B 355 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 358 CG OD1 ND2 REMARK 470 LYS B 374 CD CE NZ REMARK 470 LYS B 380 CD CE NZ REMARK 470 GLN B 383 CG CD OE1 NE2 REMARK 470 LYS B 403 CG CD CE NZ REMARK 470 GLU B 406 CG CD OE1 OE2 REMARK 470 LYS B 410 CD CE NZ REMARK 470 ARG B 459 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 462 CG OD1 OD2 REMARK 470 LYS B 464 CE NZ REMARK 470 HIS C 746 CG ND1 CD2 CE1 NE2 REMARK 470 GLN C 747 CG CD OE1 NE2 REMARK 470 ASP C 756 CG OD1 OD2 REMARK 470 ARG D 750 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 755 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE B 260 N MET B 261 1.73 REMARK 500 O PHE B 259 N ILE B 260 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE B 259 C ILE B 260 N -0.410 REMARK 500 ILE B 260 C MET B 261 N -0.405 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE B 259 O - C - N ANGL. DEV. = -11.9 DEGREES REMARK 500 ILE B 260 C - N - CA ANGL. DEV. = 25.2 DEGREES REMARK 500 ILE B 260 CA - C - N ANGL. DEV. = 14.2 DEGREES REMARK 500 ILE B 260 O - C - N ANGL. DEV. = -16.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 348 -38.30 -174.11 REMARK 500 ILE A 361 137.82 -35.07 REMARK 500 LEU A 395 47.89 -90.83 REMARK 500 LEU A 395 48.03 -90.83 REMARK 500 ASP A 474 71.70 51.19 REMARK 500 ILE B 260 -74.82 -56.95 REMARK 500 ALA B 281 56.45 39.00 REMARK 500 SER B 283 -159.38 -140.22 REMARK 500 LEU B 395 47.77 -89.44 REMARK 500 LEU B 395 47.90 -89.44 REMARK 500 ASP B 474 71.02 51.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ILE B 260 15.09 REMARK 500 REMARK 500 REMARK: NULL DBREF 7TRB A 248 476 UNP Q96RI1 NR1H4_HUMAN 258 486 DBREF 7TRB B 248 476 UNP Q96RI1 NR1H4_HUMAN 258 486 DBREF 7TRB C 744 757 PDB 7TRB 7TRB 744 757 DBREF 7TRB D 744 757 PDB 7TRB 7TRB 744 757 SEQADV 7TRB MET A 226 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY A 227 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER A 228 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER A 229 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 230 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 231 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 232 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 233 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 234 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 235 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER A 236 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER A 237 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY A 238 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLU A 239 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB THR A 240 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB VAL A 241 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB ARG A 242 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB PHE A 243 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLN A 244 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY A 245 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS A 246 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB MET A 247 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB ALA A 281 UNP Q96RI1 GLU 291 CONFLICT SEQADV 7TRB ALA A 354 UNP Q96RI1 GLU 364 CONFLICT SEQADV 7TRB MET B 226 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY B 227 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER B 228 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER B 229 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 230 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 231 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 232 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 233 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 234 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 235 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER B 236 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB SER B 237 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY B 238 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLU B 239 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB THR B 240 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB VAL B 241 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB ARG B 242 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB PHE B 243 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLN B 244 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB GLY B 245 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB HIS B 246 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB MET B 247 UNP Q96RI1 EXPRESSION TAG SEQADV 7TRB ALA B 281 UNP Q96RI1 GLU 291 CONFLICT SEQADV 7TRB ALA B 354 UNP Q96RI1 GLU 364 CONFLICT SEQRES 1 A 251 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 251 GLU THR VAL ARG PHE GLN GLY HIS MET GLU LEU THR PRO SEQRES 3 A 251 ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SER TYR SEQRES 4 A 251 ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN LYS ILE SEQRES 5 A 251 LEU LYS GLU ALA PHE SER ALA GLU GLU ASN PHE LEU ILE SEQRES 6 A 251 LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL LEU VAL SEQRES 7 A 251 GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR LEU ASP SEQRES 8 A 251 HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER ALA VAL SEQRES 9 A 251 GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE ASN LYS SEQRES 10 A 251 LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU ALA ARG SEQRES 11 A 251 ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE THR PRO SEQRES 12 A 251 MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU LYS MET SEQRES 13 A 251 THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE VAL ILE SEQRES 14 A 251 LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG GLU ALA SEQRES 15 A 251 VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL LEU GLN SEQRES 16 A 251 LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO GLN HIS SEQRES 17 A 251 PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU ARG THR SEQRES 18 A 251 PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER TRP ARG SEQRES 19 A 251 VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS GLU ILE SEQRES 20 A 251 TRP ASP VAL GLN SEQRES 1 B 251 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 251 GLU THR VAL ARG PHE GLN GLY HIS MET GLU LEU THR PRO SEQRES 3 B 251 ASP GLN GLN THR LEU LEU HIS PHE ILE MET ASP SER TYR SEQRES 4 B 251 ASN LYS GLN ARG MET PRO GLN GLU ILE THR ASN LYS ILE SEQRES 5 B 251 LEU LYS GLU ALA PHE SER ALA GLU GLU ASN PHE LEU ILE SEQRES 6 B 251 LEU THR GLU MET ALA THR ASN HIS VAL GLN VAL LEU VAL SEQRES 7 B 251 GLU PHE THR LYS LYS LEU PRO GLY PHE GLN THR LEU ASP SEQRES 8 B 251 HIS GLU ASP GLN ILE ALA LEU LEU LYS GLY SER ALA VAL SEQRES 9 B 251 GLU ALA MET PHE LEU ARG SER ALA GLU ILE PHE ASN LYS SEQRES 10 B 251 LYS LEU PRO SER GLY HIS SER ASP LEU LEU GLU ALA ARG SEQRES 11 B 251 ILE ARG ASN SER GLY ILE SER ASP GLU TYR ILE THR PRO SEQRES 12 B 251 MET PHE SER PHE TYR LYS SER ILE GLY GLU LEU LYS MET SEQRES 13 B 251 THR GLN GLU GLU TYR ALA LEU LEU THR ALA ILE VAL ILE SEQRES 14 B 251 LEU SER PRO ASP ARG GLN TYR ILE LYS ASP ARG GLU ALA SEQRES 15 B 251 VAL GLU LYS LEU GLN GLU PRO LEU LEU ASP VAL LEU GLN SEQRES 16 B 251 LYS LEU CYS LYS ILE HIS GLN PRO GLU ASN PRO GLN HIS SEQRES 17 B 251 PHE ALA CYS LEU LEU GLY ARG LEU THR GLU LEU ARG THR SEQRES 18 B 251 PHE ASN HIS HIS HIS ALA GLU MET LEU MET SER TRP ARG SEQRES 19 B 251 VAL ASN ASP HIS LYS PHE THR PRO LEU LEU CYS GLU ILE SEQRES 20 B 251 TRP ASP VAL GLN SEQRES 1 C 14 LYS ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 2 C 14 GLU SEQRES 1 D 14 LYS ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 2 D 14 GLU HET IUS A 501 87 HET IUS B 501 87 HETNAM IUS (1S,3S)-N-({4-[5-(2-FLUOROPROPAN-2-YL)-1,2,4-OXADIAZOL- HETNAM 2 IUS 3-YL]BICYCLO[2.2.2]OCTAN-1-YL}METHYL)-3-HYDROXY-N-[4'- HETNAM 3 IUS (2-HYDROXYPROPAN-2-YL)[1,1'-BIPHENYL]-3-YL]-3- HETNAM 4 IUS (TRIFLUOROMETHYL)CYCLOBUTANE-1-CARBOXAMIDE FORMUL 5 IUS 2(C35 H41 F4 N3 O4) FORMUL 7 HOH *13(H2 O) HELIX 1 AA1 THR A 250 LYS A 266 1 17 HELIX 2 AA2 PRO A 270 ILE A 277 1 8 HELIX 3 AA3 SER A 283 LYS A 308 1 26 HELIX 4 AA4 GLY A 311 LEU A 315 5 5 HELIX 5 AA5 ASP A 316 LYS A 343 1 28 HELIX 6 AA6 PRO A 345 ASN A 358 1 14 HELIX 7 AA7 SER A 362 GLU A 378 1 17 HELIX 8 AA8 THR A 382 LEU A 395 1 14 HELIX 9 AA9 ASP A 404 GLN A 427 1 24 HELIX 10 AB1 GLN A 432 THR A 446 1 15 HELIX 11 AB2 THR A 446 ASN A 461 1 16 HELIX 12 AB3 THR A 466 ASP A 474 1 9 HELIX 13 AB4 THR B 250 LYS B 266 1 17 HELIX 14 AB5 GLU B 285 LYS B 308 1 24 HELIX 15 AB6 GLY B 311 LEU B 315 5 5 HELIX 16 AB7 ASP B 316 LYS B 343 1 28 HELIX 17 AB8 GLY B 347 GLY B 360 1 14 HELIX 18 AB9 SER B 362 GLU B 378 1 17 HELIX 19 AC1 THR B 382 LEU B 395 1 14 HELIX 20 AC2 ASP B 404 GLN B 427 1 24 HELIX 21 AC3 GLN B 432 THR B 446 1 15 HELIX 22 AC4 THR B 446 ASN B 461 1 16 HELIX 23 AC5 THR B 466 ASP B 474 1 9 HELIX 24 AC6 GLN C 747 LYS C 755 1 9 HELIX 25 AC7 HIS D 746 LYS D 755 1 10 CRYST1 104.710 119.260 36.710 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009550 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008385 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027241 0.00000